Down-modulation of IgE production, as well as the reduction of IL-4, constitutes an important strategy for treating allergic diseases because the treatment of allergic asthma patients with IgE antibody was confirmed to attenuate eosinophilic airway inflammation [27] may have an important anti-allergic effect. This evidence concerns the gene IL4 and allergic asthma.